113 related articles for article (PubMed ID: 2043424)
1. Prediction of tumor radiosensitivity by hexafluoromisonidazole retention monitored by [1H]/[19F] magnetic resonance spectroscopy.
Li SJ; Jin GY; Moulder JE
Cancer Commun; 1991 May; 3(5):133-9. PubMed ID: 2043424
[TBL] [Abstract][Full Text] [Related]
2. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic resonance spectroscopy.
Jin GY; Li SJ; Moulder JE; Raleigh JA
Int J Radiat Biol; 1990 Dec; 58(6):1025-34. PubMed ID: 1978851
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Maxwell RJ; Workman P; Griffiths JR
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):925-9. PubMed ID: 2703398
[TBL] [Abstract][Full Text] [Related]
4. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
[TBL] [Abstract][Full Text] [Related]
5. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation.
Thrall DE; McEntee MC; Cline JM; Raleigh JA
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):649-59. PubMed ID: 8113108
[TBL] [Abstract][Full Text] [Related]
6. Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
Cline JM; Rosner GL; Raleigh JA; Thrall DE
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):655-62. PubMed ID: 9112464
[TBL] [Abstract][Full Text] [Related]
7. Distribution of the hypoxia marker CCI-103F in canine tumors.
Cline JM; Thrall DE; Rosner GL; Raleigh JA
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):921-33. PubMed ID: 8138446
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
Aboagye EO; Maxwell RJ; Kelson AB; Tracy M; Lewis AD; Graham MA; Horsman MR; Griffiths JR; Workman P
Cancer Res; 1997 Aug; 57(15):3314-8. PubMed ID: 9242466
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry.
Kwock L; Gill M; McMurry HL; Beckman W; Raleigh JA; Joseph AP
Radiat Res; 1992 Jan; 129(1):71-8. PubMed ID: 1728059
[TBL] [Abstract][Full Text] [Related]
10. Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines.
Li SJ; Jin GY; Fish BL; Moulder JE
Radiat Res; 1995 Jul; 143(1):45-53. PubMed ID: 7597143
[TBL] [Abstract][Full Text] [Related]
11. Correlations between in vivo 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy.
Fu KK; Wendland MF; Iyer SB; Lam KN; Engeseth H; James TL
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1341-50. PubMed ID: 2370183
[TBL] [Abstract][Full Text] [Related]
12. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Fokas E; Hänze J; Kamlah F; Eul BG; Lang N; Keil B; Heverhagen JT; Engenhart-Cabillic R; An H; Rose F
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1500-8. PubMed ID: 20637978
[TBL] [Abstract][Full Text] [Related]
13. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
Kleiter MM; Thrall DE; Malarkey DE; Ji X; Lee DY; Chou SC; Raleigh JA
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):592-602. PubMed ID: 16289910
[TBL] [Abstract][Full Text] [Related]
14. Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivity.
Saitoh J; Sakurai H; Suzuki Y; Muramatsu H; Ishikawa H; Kitamoto Y; Akimoto T; Hasegawa M; Mitsuhashi N; Nakano T
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):903-9. PubMed ID: 12377344
[TBL] [Abstract][Full Text] [Related]
15. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
Aboagye EO; Kelson AB; Tracy M; Workman P
Anticancer Drug Des; 1998 Sep; 13(6):703-30. PubMed ID: 9755726
[TBL] [Abstract][Full Text] [Related]
16. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: detection by F-19 nuclear magnetic resonance at 2.35 T.
Raleigh JA; Franko AJ; Treiber EO; Lunt JA; Allen PS
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1243-5. PubMed ID: 3744946
[TBL] [Abstract][Full Text] [Related]
17. Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS).
Papadopoulou MV; Ji M; Bloomer WD
Anticancer Res; 2006; 26(5A):3253-8. PubMed ID: 17094437
[TBL] [Abstract][Full Text] [Related]
18. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours.
Raleigh JA; La Dine JK; Cline JM; Thrall DE
Br J Cancer; 1994 Jan; 69(1):66-71. PubMed ID: 8286212
[TBL] [Abstract][Full Text] [Related]
19. Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population.
Masunaga S; Hirayama R; Uzawa A; Kashino G; Takata T; Tanaka H; Suzuki M; Kinashi Y; Liu Y; Koike S; Ando K; Ono K
Jpn J Radiol; 2010 Feb; 28(2):132-42. PubMed ID: 20182848
[TBL] [Abstract][Full Text] [Related]
20. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo.
McSheehy PM; Robinson SP; Ojugo AS; Aboagye EO; Cannell MB; Leach MO; Judson IR; Griffiths JR
Cancer Res; 1998 Mar; 58(6):1185-94. PubMed ID: 9515804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
